Why is "Fluticasone" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-08-31 04:17:24
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Fluticasone entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-08-31 and was most recently seen on 2026-08-31.
Wikipedia Overview
Fluticasone is a manufactured glucocorticoid used to treat nasal congestion. Both the esters, fluticasone propionate and fluticasone furoate, are also used as topical anti-inflammatories and inhaled corticosteroids, and are used much more commonly in comparison.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
FDA Approves Glenmark’s Generic Fluticasone Propionate Nasal Spray - HCPLive
-
A Comparative Study of Fluticasone Propionate,... : Acta Medica International - Ovid
-
Injectable Steroid for EoE - Docwire News
-
Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity - PR Newswire
-
FDA Approves First Generic Fluticasone Propionate Inhaler, Boosting Affordable Asthma Care - The American Journal of Managed Care
-
FDA Approves First Generic Fluticasone Propionate Inhalation Aerosol for Asthma Maintenance Therapy in Patients Aged 4 Years and Older - Consultant360
-
FDA approves Glenmark’s generic Flonase nasal spray - Drug Store News
-
Azelastine-fluticasone intranasal therapy: A paradigm shift in pediatric allergic rhinitis management. A point of view of the Italian Society of Pediatric Allergy and Immunology - Wiley Online Library
-
Glenmark Pharmaceuticals gains 1.4% after US FDA nod for Fluticasone nasal spray - TradingView
-
FDA Approves First Flovent Generic for Asthma - respiratory-therapy.com
-
Glenmark Gets FDA Nod for Fluticasone Propionate Inhalation Generic - Contract Pharma
-
Glenmark gets FDA nod for Fluticasone nasal spray - pharma.economictimes.indiatimes.com
-
FDA Approves Generic Flovent Inhaler for Asthma - MedPage Today
-
Glenmark Gets U.S. FDA Nod For Nasal Spray; Shares Rise 0.75% - HDFC Sky
-
Glenmark receives USFDA approval for Fluticasone Propionate Nasal Spray - Express Pharma
-
FDA gives Glenmark thumbs-up for first 'true' generic version of GSK's asthma inhaler Flovent - Fierce Pharma
-
Glenmark gets USFDA nod for generic fluticasone propionate nasal spray - BusinessLine
-
Glenmark to Launch First Generic Version of Flovent HFA - Medical Professionals Reference
-
Glenmark Gets USFDA Nod for Generic Fluticasone Nasal Spray - Rediff MoneyWiz
-
Glenmark gets US FDA approval for fluticasone propionate nasal spray - ET Manufacturing
-
European first as MHRA approves over-the-counter allergy treatment for adolescents aged 12 and over - GOV.UK
-
Glenmark Pharma Gets US FDA Approval For Fluticasone Nasal Spray In $295 Million Market - Sahi
-
Glenmark receives US-FDA approval for Fluticasone Propionate Nasal Spray - Indian Pharma Post
-
Glenmark receives US FDA approval for Fluticasone Propionate Nasal Spray - Business Standard
-
Glenmark Gets USFDA Nod for Generic Fluticasone Nasal Spray, Targets USD 295 Mn Market - Medical Dialogues
-
Glenmark Pharmaceuticals receives USFDA approval for Fluticasone Propionate Nasal Spray USP - Business Standard
-
An Open-Label, Single-Arm, Multicenter, Prospective, Post-Marketing Study to Evaluate the Effectiveness and Safety of Fluticasone Furoate/Vilanterol (FF/VI) Dry Powder Inhaler (DPI) in the Management of Asthma Patients (PROMISE-OD) - Cureus
-
Glenmark Gets USFDA Approval for Fluticasone Propionate Nasal Spray - Machine Maker
-
Glenmark Pharma gets USFDA nod for Fluticasone Propionate Nasal Spray - Business Standard
-
Nasal Saline Irrigation with Azelastine-Fluticasone Nasal Spray in Moderate-to-Severe Persistent Allergic Rhinitis: A Randomized Controlled Trial - Frontiers
-
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19 - The New England Journal of Medicine
-
Surprising Summer Skin Tips from a GREAT Dermatologist! - The People's Pharmacy
-
High-Dose Fluticasone Boosts Lung Bacteria in Severe COPD - EMJ
-
Sandoz launches azelastine/fluticasone OTC nasal spray in Germany, Switzerland - Drug Store News
-
New Real-World Evidence and Treatment Effectiveness in Patients with Asthma Newly Initiated on ICS/LABAs - EMJ
-
FDA approves first generic of Flovent for asthma - Managed Healthcare Executive
-
Inhaler switch-up not deceptive to consumers, judge finds - Courthouse News
-
Real-World Evidence Insights on Managing your Patients’ Asthma with ICS/LABA: Fluticasone Furoate/Vilanterol (FF/VI) vs BDP/Form or BUD/Form - EMJ
-
Glenmark Therapeutics USA launches fluticasone propionate nasal spray - Indian Pharma Post
-
Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhaler - The Economic Times
-
Fluticasone nasal spray approved for pharmacy sale to adolescents - thepharmacist.co.uk
-
Glenmark Pharma secures US FDA nod for Fluticasone Nasal Spray - scanx.trade
-
Validated HPLC method for simultaneous determination of azelastine hydrochloride fluticasone propionate and oxymetazoline in nasal mucosa and nasopharyngeal swabs from real human samples | Scientific Reports - Nature
-
New FDA-approved generic inhaler for kids hits market after senator's pressure - WMUR
-
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD - The New England Journal of Medicine
-
Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone - The New England Journal of Medicine
-
GSK got rich, kids got sick, when asthma inhaler was scrapped, Hassan report says - Manchester Ink Link
-
Nasal spray sold nationwide recalled due to mold, ‘life-threatening' infections possible, FDA says - NBC 5 Chicago
-
Glenmark Specialty SA receives USFDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation - Express Pharma
-
Lupin and Celon Announce Strategic Development and Licensing Agreement for Generic Advair Diskusi® - lupin.com
-
Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma - The New England Journal of Medicine
-
Anaphylactic Reaction Induced by Inhaled Fluticasone Propionate - Consultant360
-
Inhaled Fluticasone Furoate Does Not Reduce Recovery Time in COVID-19 - Infectious Disease Advisor
-
Still confused after Flovent discontinuation? What to know and do - Harvard Health
-
Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice - The New England Journal of Medicine
-
Fluticasone for Dogs: Uses, Dosage, Side Effects - GoodRx
-
Prophylactic Intranasal Corticosteroids to Prevent Contact Dermatitis From Ambulatory ECG Monitor Adhesives: A Novel Strategy - Cureus
-
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease - The New England Journal of Medicine
-
Fluticasone Propionate (XHANCE) Receives FDA Approval for Chronic Rhinosinusitis - HCPLive
-
Inhaled corticosteroids reduce growth. Or do they? - ERS - European Respiratory Society
-
Inhaled corticosteroid alternatives for young children after Flovent withdrawal - Contemporary Pediatrics
-
Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India - Cureus
-
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol - Teva Pharmaceuticals
-
Pro-and anti-inflammatory effects of glucocorticoid Fluticasone on ovarian and immune functions in commercial-aged laying hens | Scientific Reports - Nature
-
Novel Fluticasone Delivery System Found to Reduce Nasal Polyps Severity - The American Journal of Managed Care
-
Glenmark Pharma Gets US FDA Approval For Fluticasone Nasal Spray Targeting $384 Million OTC Market - scanx.trade
-
Fluticasone Furoate Does Not Cut Time to COVID-19 Symptom Resolution - Vaccine Advisor
-
European first as MHRA approves over-the-counter allergy treatment for adolescents aged 12 and over - Allergy UK
-
Three ways to ensure your child has the proper asthma medication - Boston Children's Answers
-
Asthma Visits More Common After Flovent No Longer Manufactured - Epic Research
-
Glenmark gets USFDA nod for generic Flovent with 180‑day CGT exclusivity - Moneycontrol.com
-
Generic and brand-name fluticasone-salmeterol are equally effective in COPD management - 2 Minute Medicine
-
Efficacy of New Exhalation Delivery System with Fluticasone (EDS-FLU) in Patients Who Remain Symptomatic on Standard Nasal Steroid Sprays - MedicalResearch.com
-
Fluticasone Furoate Gets FDA Approval for Pediatric Asthma Maintenance - HCPLive
-
Rhinocort vs. Flonase Nasal Spray: Which Is Better for Allergies? - GoodRx
-
COPD Treatment May Increase Risk of Tuberculosis - Infectious Disease Advisor
-
Sandoz launches allergy relief nasal spray in Germany and Switzerland - Pharmafile
-
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD - The New England Journal of Medicine
-
Darunavir/Fluticasone-propionate/Ritonavir interaction - Springer Nature Link
-
Figure 9.6, [Examples of Corticosteroid Medications (fluticasone...]. - Nursing Pharmacology - National Institutes of Health (NIH) | (.gov)
-
Symptom Burden, QOL in CRSwNP Significantly Improved With Novel Fluticasone Delivery System - The American Journal of Managed Care
-
Fluticasone Exhalation Delivery System Reduced Exacerbations, Need for Antibiotics in Patients with Chronic Sinusitis - Patient Care Online
-
Glenmark wins US nod for Fluticasone inhaler, to get 180-day exclusivity - CNBC TV18
-
What is Flovent? Doctors, parents scrambling after asthma inhaler switch takes popular medication for children off the market - ABC7 New York
-
What Is It Like to Take Flonase for Allergy Relief? - GoodRx
-
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials - The Lancet
-
Fluticasone propionate injection improves osteoarthritis knee pain over 12 weeks - Healio
-
Glenmark Gets USFDA Approval for Fluticasone Nasal Spray - GK Today
-
Long-Acting Fluticasone Propionate Offers Hope in Knee OA - Medscape
-
Combination Therapy With Azelastine/Fluticasone Superior to Monotherapy in Allergic Rhinitis - Pulmonology Advisor
-
Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study - Nature
-
17-oxo-DHA displays additive anti-inflammatory effects with fluticasone propionate and inhibits the NLRP3 inflammasome - Nature
-
Reacting to the FDA Approval of Fluticasone Propionate Nasal Spray, with James Palmer, MD - HCPLive
-
First Treatment Approved for Chronic Rhinosinusitis Without Nasal Polyps - MedPage Today
-
Fluticasone/salmeterol reduces remodelling and neutrophilic inflammation in severe equine asthma - Nature
-
Eucalyptus oil nanoemulsion for enhanced skin deposition of fluticasone propionate in psoriatic plaques: A combinatorial anti-inflammatory effect to suppress implicated cytokines - Wiley Online Library
-
Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms - Duke Health
-
Fluticasone-propionate/lopinavir/ritonavir interaction - Springer Nature Link
-
Generic Fluticasone–Salmeterol Inhaler for COPD Matches Branded Product - MedPage Today
-
Advair Side Effects: What You Need to Know - GoodRx
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.